Effect of topical application of capsaicin and its related compounds on dermal insulin-like growth factor-I levels in mice and on facial skin elasticity in humans

Growth Hormone and IGF Research

Volumn 17, Issue 2, 2007, Pages 171-176

  Harada, Naoaki ^a   Okajima, Kenji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Anandamide; Calcitonin gene related peptide; Capsaicin; Capsiate; Insulin like growth factor I; Nonylic acid vanillylamide; Sensory neurons

Indexed keywords

ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CAPSAICIN DERIVATIVE; CAPSIATE; DIHYDROCAPSAICIN; DIHYDROCAPSIATE; NONIVAMIDE; NORDIHYDROCAPSAICIN; NORDIHYDROCAPSIATE; SOMATOMEDIN C; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEEK; CONTROLLED STUDY; CUTANEOUS PARAMETERS; ELASTICITY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN EXPERIMENT; MALE; MORPHOLOGY; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR UPREGULATION; SENSORY NERVE CELL; TIME; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANIMALS; ARACHIDONIC ACIDS; CAPSAICIN; DERMIS; ELASTICITY; FACE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; POLYUNSATURATED ALKAMIDES; SKIN;

EID: 34047149820     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.12.005     Document Type: Article

References (33)

1. Slominski A., and Wortsman J. Neuroendocrinology of the skin. Endocr. Rev. 21 (2000) 457-487
2. Slominski A., Wortsman J., Luger T., Paus R., and Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80 (2000) 979-1020
3. Maggi C.A., and Meli A. The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen. Pharmacol. 19 (1988) 1-4
4. Dray A. Inflammatory mediators of pain. Br. J. Anaesth. 75 (1995) 125-131
5. Rosenfeld M.G., Mermod J.J., Amara S.G., et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304 (1983) 129-135
6. Brain S.D., Williams T.J., Tippins J.R., Morris H.R., and MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 313 (1985) 54-56
7. Millet I., Phillips R.J., Sherwin R.S., et al. Inhibition of NF-κB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J. Biol. Chem. 275 (2000) 15114-15121
8. Harada N., Okajima K., Uchiba M., and Katsuragi K. Ischemia/reperfusion-induced increase in the hepatic level of prostacyclin is mainly mediated by activation of capsaicin-sensitive sensory neurons in rats. J. Lab. Clin. Med. 139 (2002) 218-226
9. Harada N., Okajima K., Uchiba M., and Katsuragi T. Contribution of capsaicin-sensitive sensory neurons to stress-induced increases in gastric tissue levels of prostaglandins in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G1214-G1224
10. Okajima K., Isobe H., Uchiba M., and Harada H. Role of sensory neuron in reduction of endotoxin-induced hypotension in rats. Crit. Care Med. 33 (2005) 847-854
11. Okajima K., and Harada N. Regulation of inflammatory responses by sensory neurons: molecular mechanism(s) and possible therapeutic applications. Curr. Med. Chem. 13 (2006) 2241-2251
12. Slominski A., Malarkey W.B., Wortsman J., Asa S.L., and Carlson A. Human skin expresses growth hormone but not the prolactin gene. J. Lab. Clin. Med. 136 (2000) 476-481
13. Daughaday W.H., and Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10 (1989) 68-91
14. Carroll P.V. Treatment with growth hormone and insulin-like growth factor-I in critical illness. Best Pract. Res. Clin. Endocrinol. Metab. 15 (2001) 435-451
15. Oakes S.R., Haynes K.M., Waters M.J., Herington A.C., and Werther G.A. Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J. Clin. Endocrinol. Metab. 75 (1992) 1368-1373
16. Tavakkol A., Varani J., Elder J.T., and Zouboulis C.C. Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch. Dermatol. Res. 291 (1999) 643-651
17. Harrison C.A., Gossiel F., Bullock A.J., Sun T., Blumsohn A., and Mac Neil S. Investigation of keratinocyte regulation of collagen I synthesis by dermal fibroblasts in a simple in vitro model. Br. J. Dermatol. 154 (2006) 401-410
18. Vignery A., and McCarthy T.L. The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts. Bone 18 (1996) 331-335
19. Hodak E., Gottlieb A.B., Anzilotti M., and Krueger G. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia. J. Invest. Dermatol. 106 (1996) 564-570
20. Tavakkol A., Elder J.T., Griffiths C.E., et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-I) and IGF-I receptor mRNA and proteins in human skin. J. Invest. Dermatol. 99 (1992) 343-349
21. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24 (1988) 739-768
22. Kawase T., Okuda K., Wu C.H., Yoshie H., Hara K., and Burns D.M. Calcitonin gene-related peptide acts as a mitogen for human Gin-1 gingival fibroblasts by activating the MAP kinase signalling pathway. J. Periodontal. Res. 34 (1999) 160-168
23. Rashid M.H., Inoue M., Kondo S., Kawashima T., Bakoshi S., and Ueda H. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J. Pharmacol. Exp. Ther. 304 (2003) 940-948
24. Sirotkin A.V., Florkovicova I., Makarevich A.V., et al. Oxytocin mediates some effects of insulin-like growth factor-I on porcine ovarian follicles. J. Reprod. Dev. 49 (2003) 141-149
25. Sumino H., Ichikawa S., Abe M., et al. Effects of aging and postmenopausal hypoestrogenism on skin elasticity and bone mineral density in Japanese women. Endocr. J. 51 (2004) 159-164
26. Krane J.F., Murphy D.P., Carter D.M., and Kruege J.G. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J. Invest. Dermatol. 96 (1991) 419-424
27. Pierard G.E. A critical approach to in vivo mechanical testing of the skin. In: Leveque T.L. (Ed). Cutaneous Investigation in Health and Disease (1989), Dekker, New York 215-240
28. Castelo-Branco C., Pons F., Gratacos E., Fortuny A., Vanrell J.A., and Gonzalez-Merlo J. Relationship between skin collagen and bone changes during aging. Maturitas 18 (1994) 199-206
29. Pedersen S.A., Welling K., Michaelsen K.F., Jorgensen J.O., Christiansen J.S., and Skakkebaek N.E. Reduced sweating in adults with growth hormone deficiency. Lancet 2 (1989) 681-682
30. Lange M., Thulesen J., Feldt-Rasmussen U., et al. Skin morphological changes in growth hormone deficiency and acromegaly. Eur. J. Endocrinol. 145 (2001) 147-153
31. Serban G., Edelberg R., Garcia M., and Hambridge A. Intraepidermal sweat levels and the viscoelastic properties of human skin. Bioeng. Skin 2 (1986) 134
32. Brincat .M., Kabalan S., Studd J.W., Moniz C.F., de Trafford J., and Montgomery J. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstet. Gynecol. 70 (1987) 840-845
33. Slominski A. Neuroendocrine system of the skin. Dermatology 211 (2005) 199-208